206
Participants
Start Date
October 31, 2015
Primary Completion Date
August 31, 2016
Study Completion Date
August 31, 2016
PF-06291874
study drug to be given as an oral tablet at 30, 60 or 100 mg
Placebo
oral tablet
National Clinical Research - Richmond, Inc., Richmond
Randolph Medical Associates, Asheboro
High Point Clinical Trials Center, LLC, High Point
WR-Mount Vernon Clinical Research, LLC, Sandy Springs
Avail Clinical Research, LLC, DeLand
Clinical Research of South Florida, Coral Gables
Suncoast Research Group, Llc, Miami
QPS-MRA, LLC (Miami Research Associates), South Miami
Palm Beach Research Center, West Palm Beach
Aventiv Research, Columbus
Midwest Institute for Clinical Research, Indianapolis
Lillestol Research, LLC, Fargo
St. Louis Clinical Trials, LC, St Louis
Crescent City Clinical Research Center, LLC, Metairie
Juno Research, LLC, Houston
Texas Center for Drug Development, Inc., Houston
Juno Research, LLC, Katy
Northeast Clinical Research of San Antonio, LLC, Schertz
Clinical Trials of Texas, Inc., San Antonio
ALAS Science Clinical Research, Las Vegas
National Research Institute, Los Angeles
Empire Clinical Research, Upland
Encompass Clinical Research, Spring Valley
Anaheim Clinical Trials, LLC, Anaheim
NRC Research Institute, Orange
Diablo Clinical Research, Inc, Walnut Creek
Sierra Clinical Research, Roseville
East-West Medical Research Institute, Honolulu
Comprehensive Clinical Research, Berlin
Clinilabs Inc., Eatontown
Pharmaceutical Research Associates, Inc., Marlton
TLB Research, Trenton
Aggarwal and Associates Limited, Brampton
LMC Clinical Research Inc. (Thornhill), Thornhill
LMC Clinical Research Inc. (Bayview), Toronto
Manna Research, Toronto
Manna Research Inc., Lévis
Omnispec Clinical Research, Inc., Mirabel
Lead Sponsor
Pfizer
INDUSTRY